People living with HIV (PLWH) are at high risk of herpes zoster (HZ). The recombinant anti-HZ vaccine (RZV), approved by European Medicines Agency (EMA) in 2018, has been shown to be effective and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback